A spike- and nucleoprotein-targeting mRNA vaccine for SARS-CoV-2
An mRNA vaccine encoding the SARS-CoV-2 N nucleocapsid protein and the SARS-CoV-2 S spike protein could protect against a wide range of variants, including Delta and Omicron.
In mice, vaccination with a nucleoside-modified mRNA construct encoding the full-length SARS-CoV-2 N protein from the ancestral SARS-CoV-2 strain and delivered via lipid nanoparticles increased SARS-CoV-2 N-specific CD4+ and CD8+ T cell activation in the spleen and IgG levels in the serum compared with vehicle...
BCIQ Company Profiles